Lv11
88 积分 2024-01-05 加入
Tumour burden and efficacy of immune-checkpoint inhibitors
14天前
已完结
Muscles, exercise and obesity: skeletal muscle as a secretory organ
1个月前
已完结
Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation
3个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
4个月前
已完结
Insights into the success and failure of systemic therapy for hepatocellular carcinoma
6个月前
已完结
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
7个月前
已完结
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma
8个月前
已完结
Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
9个月前
已完结
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)
9个月前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
9个月前
已完结
皖公网安备34019202002308
